{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-054784","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2025-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.905668+00:00","generated_at":"2026-05-24T18:44:51.808509+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ORIC Pharmaceuticals amends inducement equity plan, adds 1.1M shares to reserve","bullets":["Compensation Committee approved Amended and Restated 2022 Inducement Plan, adding 1,100,000 shares to reserve.","Total shares reserved under the plan increased to 2,250,000 shares.","Amendment adopted without stockholder approval under Nasdaq Listing Rules.","Awards are inducement material for new employees and non-employee directors under Nasdaq Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-054784","json":"https://secwatch.observer/filing/0001193125-25-054784.json","markdown":"https://secwatch.observer/filing/0001193125-25-054784.md","text":"https://secwatch.observer/filing/0001193125-25-054784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312525054784/0001193125-25-054784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312525054784/d873253d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T18:44:51.808509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}